Alan Musso

2023

In 2023, Alan Musso earned a total compensation of $1.9M as Chief Financial Officer at Fulcrum Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$61,700
Option Awards$1,605,754
Salary$180,682
Other$31,697
Total$1,879,833

Musso received $1.6M in option awards, accounting for 85% of the total pay in 2023.

Musso also received $61.7K in non-equity incentive plan, $180.7K in salary and $31.7K in other compensation.

Rankings

In 2023, Alan Musso's compensation ranked 560th out of 2,790 executives tracked by ExecPay. In other words, Musso earned more than 79.9% of executives.

ClassificationRankingPercentile
All
560
out of 2,790
80th
Division
Manufacturing
319
out of 1,530
79th
Major group
Chemicals And Allied Products
224
out of 869
74th
Industry group
Drugs
221
out of 832
73rd
Industry
Pharmaceutical Preparations
137
out of 597
77th
Source: SEC filing on April 19, 2024.

Musso's colleagues

We found five more compensation records of executives who worked with Alan Musso at Fulcrum Therapeutics in 2023.

2023

Alex Sapir

Fulcrum Therapeutics

Chief Executive Officer

2023

Curtis Oltmans

Fulcrum Therapeutics

Chief Legal Officer

2023

Mel Hayes

Fulcrum Therapeutics

Executive Vice President, Patient Affairs

2023

Bryan Stuart

Fulcrum Therapeutics

Chief Executive Officer

2023

Robert Gould

Fulcrum Therapeutics

Chief Executive Officer

News

In-depth

You may also like